Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward W Roberts

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 22, 2024
Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell ActivityZhiming Cheng, Emily J Thompson, Lorena Mendive-Tapia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancerChristine Feig, James O Jones, Matthew Kraman, et al.
Cell|April 9, 2019
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4<sup>+</sup> T Cell ImmunityMikhail Binnewies, Adriana M Mujal, Joshua L Pollack, et al.
Nature Medicine|April 25, 2018
Understanding the tumor immune microenvironment (TIME) for effective therapyMikhail Binnewies, Edward W Roberts, Kelly Kersten, et al.
The Journal of Experimental Medicine|May 29, 2013
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemiaEdward W Roberts, Andrew Deonarine, James O Jones, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockadeMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
British Journal of Cancer|May 6, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesisAlessandra I Riggio, Kerri Sweeney, Robin Shaw, et al.
Nature Cancer|January 29, 2024
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanomaMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Cell Reports|March 16, 2026
Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancerFrédéric Fercoq, Gemma S Cairns, Victoria L Bridgeman, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 22, 2024
Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell ActivityZhiming Cheng, Emily J Thompson, Lorena Mendive-Tapia, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancerChristine Feig, James O Jones, Matthew Kraman, et al.
Cell|April 9, 2019
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4<sup>+</sup> T Cell ImmunityMikhail Binnewies, Adriana M Mujal, Joshua L Pollack, et al.
Nature Medicine|April 25, 2018
Understanding the tumor immune microenvironment (TIME) for effective therapyMikhail Binnewies, Edward W Roberts, Kelly Kersten, et al.
The Journal of Experimental Medicine|May 29, 2013
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemiaEdward W Roberts, Andrew Deonarine, James O Jones, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockadeMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
British Journal of Cancer|May 6, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesisAlessandra I Riggio, Kerri Sweeney, Robin Shaw, et al.
Nature Cancer|January 29, 2024
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanomaMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Cell Reports|March 16, 2026
Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancerFrédéric Fercoq, Gemma S Cairns, Victoria L Bridgeman, et al.
Pageof 4